Impulse Magnetic-Field Therapy for E.D. 80% effective - maybe more
Posted: Wed Feb 10, 2021 2:38 pm
80% efficacy cited. The study is small (20 men, double-blind) but very interesting results.
Impulse Magnetic-Field Therapy for Erectile Dysfunction
Rainer B. Pelka, Ph.D.
Universität der Bundeswehr München
Neubiberg/Munich, Germany
Christof Jaenicke, M.D.
Joerg Gruenwald, Ph.D.
PhytoPharm Consulting
Institute for Phytopharmaceuticals
Berlin, Germany
ABSTRACT
This double-blind, placebo-controlled study assessed the efficacy of 3 weeks of impulse magnetic-field therapy for erectile dysfunction (ED). Twenty volunteers who suffered from ED or orgasmic disturbances were randomly assigned to either active treatment or placebo (n = 10 each). Efficacy was assessed in terms of intensity and duration of erection, general well-being, sexual activity, and warm sensation in the genital area. In the active-treatment group, all efficacy endpoints were significantly improved at study end (P.01), with 80% reporting increases in intensity and duration of erection, frequency of genital warmth, and general wellbeing. The remaining 20%, who experienced minor improvements, were found to have an influenza-like infection after the study that may have influenced their results. Only 30% of the placebo group noted some improvement in their sexual activity; 70% had no change. No side effects were reported.
Impulse Magnetic-Field Therapy for Erectile Dysfunction
Rainer B. Pelka, Ph.D.
Universität der Bundeswehr München
Neubiberg/Munich, Germany
Christof Jaenicke, M.D.
Joerg Gruenwald, Ph.D.
PhytoPharm Consulting
Institute for Phytopharmaceuticals
Berlin, Germany
ABSTRACT
This double-blind, placebo-controlled study assessed the efficacy of 3 weeks of impulse magnetic-field therapy for erectile dysfunction (ED). Twenty volunteers who suffered from ED or orgasmic disturbances were randomly assigned to either active treatment or placebo (n = 10 each). Efficacy was assessed in terms of intensity and duration of erection, general well-being, sexual activity, and warm sensation in the genital area. In the active-treatment group, all efficacy endpoints were significantly improved at study end (P.01), with 80% reporting increases in intensity and duration of erection, frequency of genital warmth, and general wellbeing. The remaining 20%, who experienced minor improvements, were found to have an influenza-like infection after the study that may have influenced their results. Only 30% of the placebo group noted some improvement in their sexual activity; 70% had no change. No side effects were reported.